Extracorporeal Immunoglobulin Elimination for the Treatment of Severe Myasthenia Gravis

by M. Blaha, J. Pit'ha, V. Blaha, M. Lanska, J. Maly, S. Filip, H. Langrova
Published 2010-01-01

Use of Ultra High Performance Liquid Chromatography-Tandem Mass Spectrometry to Demonstrate Decreased Serum Statin Levels after Extracorporeal LDL-Cholesterol Elimination

by M. Bláha, H. Vlčková, L. Nováková, D. Solichová, P. Solich, M. Lánská, J. Malý, V. Bláha
Published 2011-01-01

Lipoprotein-Associated Phospholipase A2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus

by J. Fortunato, V. Bláha, J. Bis, J. Št’ásek, C. Andrýs, J. Vojáček, B. Jurašková, L. Sobotka, P. Polanský, M. Brtko
Published 2014-01-01

Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients

by J. Víšek, M. Bláha, V. Bláha, M. Lášticová, M. Lánska, C. Andrýs, J. Duintjer Tebbens, Ivone Cristina Igreja e Sá, K. Tripská, M. Vicen, I. Najmanová, P. Nachtigal
Published 2021-02-01